A Professional & Personal Networking Site for all People related to Cardiology
http://newmedia.ufm.edu/maniscalconanobacterium
Our principal cardiology investigator, Benedict Maniscalco, MD, FACC in a lecture on the development of pathological calcification in CAD. Dr. Maniscalco was the lead investigator for my NanobacTX clinical trial some years ago....the study was published in a cardiology journal. Please feel free to email me if any questions: info@nanobiotech.us or visit…
ContinueAdded by Gary S. Mezo on January 23, 2012 at 6:40pm — No Comments
Aims To compare the long-term outcome after percutaneous coronary intervention with ‘new-generation’ drug-eluting stents (n-DES) to ‘older generation’ DES (o-DES), and bare-metal stents (BMS) in a real-world population.
Methods and results We evaluated 94 384 consecutive stent implantations (BMS, n = 64 631; o-DES, n = 19 202; n-DES,…
Added by Cardiology Network Team on January 20, 2012 at 12:48pm — No Comments
Context The role of diet composition in response to overeating and energy dissipation in humans is unclear.
Objective To evaluate the effects of overconsumption of low, normal, and high protein diets on weight gain, energy expenditure, and body composition.
Design, Setting, and Participants A single-blind, randomized controlled trial of 25 US healthy, weight-stable male and female volunteers, aged 18…
ContinueAdded by Cardiology Network Team on January 20, 2012 at 12:47pm — No Comments
As you go to conferences, you will hear more and more about the conus and its' importance. The conus is simply the pyramidal structure that is the right ventricular outflow tract (RVOT). The AV valve apparatus and the semi-lunar valve structure (conotruncal apparatus), is essentially the skeleton of the heart that is a fibromuscular structure that forms the valves of the heart.
The entire AV,…
Added by Kenneth Heiden RDCS, RVT on January 1, 2012 at 6:09am — No Comments
3D echo is in the process of revolutionizing pediatric echocardiography. It is like the difference between looking at a crude snapshot of an infant's heart in the womb, as opposed to a 3D movie of that same infant's heart.
Many cities have 3D images of babies on their billboards advertising their hospitals, as if you have taken a picture of that baby in…
Added by Kenneth Heiden RDCS, RVT on December 31, 2011 at 10:12am — No Comments
The investigation in the Dutch scientific misconduct case has now spread to the Leiden University Medical Center, according to media reports in the Netherlands. The case first came to public attention last month when the Erasmus Medical Center in Rotterdam fired prominent cardiovascular researcher Don Poldermans. (…
ContinueAdded by Cardiology Network Team on December 15, 2011 at 2:30pm — No Comments
Lipitor (atorvastatin) was the top-selling prescription medication in the United States in 2010, earning its manufacturer, Pfizer, more than $7 billion in total revenue. The overall market for prescription lipid-lowering drugs continues to grow; this drug class had greater prescription volume than any other class in 2010, with statins dominating the market.1…
ContinueAdded by Cardiology Network Team on December 9, 2011 at 12:27pm — 3 Comments
Two treatments for smoking cessation—varenicline and bupropion—carry Boxed Warnings from the U.S. Food and Drug Administration (FDA) about suicidal/self-injurious behavior and depression. However, some epidemiological studies report an increased risk in smoking or smoking cessation independent of treatment, and differences between drugs are unknown.
From the FDA's Adverse Event Reporting System (AERS) database from 1998 through September 2010…
ContinueAdded by Cardiology Network Team on December 9, 2011 at 12:26pm — No Comments
The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.
About 20 million people in the United States have type 2 diabetes, and they often have high cholesterol levels as well.…
ContinueAdded by Cardiology Network Team on October 10, 2011 at 10:40am — No Comments
SAN FRANCISCO – Scios Inc., a subsidiary of pharmaceutical giant Johnson & Johnson, pleaded guilty today to a misdemeanor violation of the Food, Drug and Cosmetic Act (FDCA) for introducing into interstate commerce its heart failure drug, Natrecor, for a use that was not approved by the Food and Drug Administration (FDA), the Justice Department announced. …
Added by Cardiology Network Team on October 10, 2011 at 10:36am — No Comments
Added by Dr.Ashok Kumar Prasad on October 7, 2011 at 12:00pm — No Comments
Last fall, Sgt. Timothy Gall, an Army medic stationed at Fort Belvoir, sought clues to the multiple sclerosis and heart disease that ran in his family by looking into his DNA. All it took was some spit and about a thousand bucks.
He didn't go to a doctor. Instead, Gall, 30, joined the growing number of consumers ordering scans of their DNA directly from private companies. A handful of companies such as 23andMe, Navigenics and Decode Genetics offer customers a personal peek at their…
ContinueAdded by Cardiology Network Team on September 20, 2011 at 11:04pm — No Comments
Objective: We compared microemboli on transcranial Doppler (TCD) with carotid ulcerations on 3D ultrasound (US) as an additional method for identifying the small proportion of patients with asymptomatic carotid stenosis (ACS) who can benefit from revascularization such as endarterectomy or stenting.
Methods: Patients with ACS (n = 253) with carotid stenosis…
Added by Cardiology Network Team on September 20, 2011 at 11:02pm — No Comments
Background—Regional ST-segment–elevation myocardial infarction systems are being developed to improve timely access to primary percutaneous coronary intervention (PCI). System delays may diminish the mortality benefit achieved with primary PCI in ST-segment–elevation myocardial infarction patients, but the specific reasons for and clinical impact of delays in patients transferred for PCI are unknown.…
Added by Cardiology Network Team on September 20, 2011 at 11:01pm — No Comments
On September 13, 2011, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).
Cardiovascular disease (CVD) causes one in three (approximately 800,000) deaths reported each year in the United States (1). Annual direct and overall costs resulting from CVD are estimated at $273 billion and $444 billion, respectively…
ContinueAdded by Cardiology Network Team on September 20, 2011 at 11:00pm — No Comments
Added by Dr.Ashok Kumar Prasad on August 28, 2011 at 11:00am — No Comments
Added by Dr.Pratap on August 25, 2011 at 5:04am — No Comments
Elsevier, provider of scientific, technical and medical information products and services, announced its Braunwald's Heart Disease Practice Guides App for iPad, iPhone and iPod Touch is now available on the App Store.
The app includes content from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition, and provides the most up-to-date, evidence-based cardiology clinical practice guidelines from the American College of Cardiology (ACC) and the American Heart…
ContinueAdded by Dr.Pratap on August 25, 2011 at 5:00am — No Comments
Download Links
http://www.filefactory.com/file/cdce749/n/Hurst_s_The_Heart_13th_2011_Pg.part1.rar
http://www.filefactory.com/file/cdce7f7/n/Hurst_s_The_Heart_13th_2011_Pg.part2.rar
…
ContinueAdded by Dr.Pratap on August 25, 2011 at 4:56am — No Comments
Added by Dr.Pratap on August 25, 2011 at 4:49am — No Comments
2012
2011
2010
2009
2008